Position in ABBV
as of Jun 30, 2026
· filed Aug 20, 2026
Position Value
$7,471,443
+$992,199 QoQ
Shares Held
29,691
-0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#1,067
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Harvest Fund Management Co., Ltd holds $61,466,678 across 9 Drug Manufacturers - General names. ABBV ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,480 | $19,766,608 | |
| 2 | AMGN |
Amgen Inc
|
50,516 | $18,292,853 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
105,327 | $13,307,013 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
29,691 | $7,471,443 | |
| 5 | JNJ |
Johnson & Johnson
|
4,465 | $1,133,976 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,547 | $492,478 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,600 | $462,600 | |
| 8 | NVS |
Novartis AG
|
2,900 | $454,488 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,471,443 | 29,691 | Shares | Sole | 2026-08-20 | |
| 2026-03-31 | $6,479,244 | 29,791 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,490,002 | 37,157 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $9,111,793 | 39,353 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,339,359 | 28,765 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $9,412,895 | 44,926 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,434,927 | 8,075 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,544,212 | 23,011 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,307,248 | 19,282 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $3,646,370 | 20,024 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $229,355 | 1,480 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $814,165 | 5,462 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $834,382 | 6,193 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $2,548,485 | 15,991 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,779,692 | 17,200 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,940,408 | 14,458 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,620,261 | 17,108 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,544,802 | 15,698 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,186,374 | 8,762 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $704,067 | 6,527 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,119,191 | 9,936 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,028,522 | 9,504 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,068,071 | 9,968 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $918,468 | 10,486 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,178,061 | 11,999 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $742,014 | 9,739 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||